1.The current research status and mechanism of appetite change after bariatric surgery
Liuqing XI ; Yingkai SUN ; Jie HONG
Chinese Journal of Endocrinology and Metabolism 2017;33(8):714-718
Bariatric surgery is one of the most effective way to lose weight,which suppresses appetite through the central nervous system. The mechanisms of appetite change may include gut hormones, adipokines, as well as microbiota in the intestine.
2.MiRNA-203 suppresses tumor cell proliferation, migration and invasion by targeting Slug in gastric cancer.
Liuqing YANG ; Hongwei LIANG ; Yanbo WANG ; Shanting GAO ; Kai YIN ; Zhijian LIU ; Xi ZHENG ; Ying LV ; Lei WANG ; Chen-Yu ZHANG ; Xi CHEN ; Guifang XU ; Weijie ZHANG ; Xiaoping ZOU
Protein & Cell 2016;7(5):383-387
3' Untranslated Regions
;
Animals
;
Antagomirs
;
metabolism
;
Base Sequence
;
Binding Sites
;
Cell Line, Tumor
;
Cell Movement
;
Cell Proliferation
;
Humans
;
Mice
;
MicroRNAs
;
antagonists & inhibitors
;
genetics
;
metabolism
;
RNA Interference
;
RNA, Messenger
;
metabolism
;
RNA, Small Interfering
;
metabolism
;
Rats
;
Sequence Alignment
;
Snail Family Transcription Factors
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Stomach Neoplasms
;
genetics
;
pathology
3.Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis.
Shoubin ZHAN ; Ping YANG ; Shengkai ZHOU ; Ye XU ; Rui XU ; Gaoli LIANG ; Chenyu ZHANG ; Xi CHEN ; Liuqing YANG ; Fangfang JIN ; Yanbo WANG
Frontiers of Medicine 2022;16(2):216-226
Hepatocellular carcinoma (HCC), which makes up the majority of liver cancer, is induced by the infection of hepatitis B/C virus. Biomarkers are needed to facilitate the early detection of HCC, which is often diagnosed too late for effective therapy. The tRNA-derived small RNAs (tsRNAs) play vital roles in tumorigenesis and are stable in circulation. However, the diagnostic values and biological functions of circulating tsRNAs, especially for HCC, are still unknown. In this study, we first utilized RNA sequencing followed by quantitative reverse-transcription PCR to analyze tsRNA signatures in HCC serum. We identified tRF-Gln-TTG-006, which was remarkably upregulated in HCC serum (training cohort: 24 HCC patients vs. 24 healthy controls). In the validation stage, we found that tRF-Gln-TTG-006 signature could distinguish HCC cases from healthy subjects with high sensitivity (80.4%) and specificity (79.4%) even in the early stage (Stage I: sensitivity, 79.0%; specificity, 74.8%; 155 healthy controls vs. 153 HCC patients from two cohorts). Moreover, in vitro studies indicated that circulating tRF-Gln-TTG-006 was released from tumor cells, and its biological function was predicted by bioinformatics assay and validated by colony formation and apoptosis assays. In summary, our study demonstrated that serum tsRNA signature may serve as a novel biomarker of HCC.
Biomarkers
;
Biomarkers, Tumor/genetics*
;
Carcinoma, Hepatocellular/diagnosis*
;
Hepatitis B virus
;
Humans
;
Liver Neoplasms/diagnosis*
;
RNA, Transfer/genetics*